APA (7th ed.) Citation

V, C., S, B., R, R., T, A., O, S., R, R., . . . GJ, V. (2022). Clinical utility of vinblastine therapeutic drug monitoring for the treatment of infantile myofibroma patients: A case series. Pediatric blood & cancer, 69(7), e29722. https://doi.org/10.1002/pbc.29722

Chicago Style (17th ed.) Citation

V, Carruthers, et al. "Clinical Utility of Vinblastine Therapeutic Drug Monitoring for the Treatment of Infantile Myofibroma Patients: A Case Series." Pediatric Blood & Cancer 69, no. 7 (2022): e29722. https://doi.org/10.1002/pbc.29722.

MLA (9th ed.) Citation

V, Carruthers, et al. "Clinical Utility of Vinblastine Therapeutic Drug Monitoring for the Treatment of Infantile Myofibroma Patients: A Case Series." Pediatric Blood & Cancer, vol. 69, no. 7, 2022, p. e29722, https://doi.org/10.1002/pbc.29722.